|
rs779188587
|
|
Allanson Pantzar McLeod syndrome
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
|
rs778390161
|
|
Allanson Pantzar McLeod syndrome
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
|
rs4351
|
|
Serum albumin measurement
|
A |
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide assessment of variability in human serum metabolism.
|
23281178 |
2013 |
|
rs4344
|
|
Blood Protein Measurement
|
A |
0.700 |
GeneticVariation
|
GWASCAT |
Co-regulatory networks of human serum proteins link genetics to disease.
|
30072576 |
2018 |
|
rs4343
|
|
Serum albumin measurement
|
G |
0.700 |
GeneticVariation
|
GWASDB |
Genetic determinants influencing human serum metabolome among African Americans.
|
24625756 |
2014 |
|
rs4343
|
|
Serum albumin measurement
|
A |
0.700 |
GeneticVariation
|
GWASDB |
Genetic determinants influencing human serum metabolome among African Americans.
|
24625756 |
2014 |
|
rs4329
|
|
Glucose measurement
|
G |
0.700 |
GeneticVariation
|
GWASDB |
Human metabolic individuality in biomedical and pharmaceutical research.
|
21886157 |
2011 |
|
rs4329
|
|
elevated blood glucose level
|
G |
0.700 |
GeneticVariation
|
GWASDB |
Human metabolic individuality in biomedical and pharmaceutical research.
|
21886157 |
2011 |
|
rs4311
|
|
Alzheimer's Disease
|
|
0.700 |
GeneticVariation
|
GWASCAT |
GWAS on family history of Alzheimer's disease.
|
29777097 |
2018 |
|
rs4308
|
|
Diastolic blood pressure
|
A |
0.700 |
GeneticVariation
|
GWASCAT |
Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk.
|
28135244 |
2017 |
|
rs4295
|
|
Diastolic blood pressure
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation.
|
27841878 |
2017 |
|
rs4295
|
|
Systolic Pressure
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation.
|
27841878 |
2017 |
|
rs4291
|
|
Systolic Pressure
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
Trans-ethnic association study of blood pressure determinants in over 750,000 individuals.
|
30578418 |
2019 |
|
rs28730839
|
|
Low density lipoprotein cholesterol measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
|
rs28730839
|
|
Serum LDL cholesterol measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
|
rs149155892
|
|
Body Height
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
rs1267969615
|
|
Myocardial Infarction
|
|
0.100 |
GeneticVariation
|
BEFREE |
To determine whether the DNA polymorphisms in A:POE (epsilon2, epsilon3, and epsilon4 alleles), A:GT (M235T), A:T1R (1166 A:/C:), and ACE (I:/D:) are associated with early onset of myocardial infarction (MI), we genotyped 220 patients and 200 controls <55 years of age.
|
11106322 |
2000 |
|
rs1267969615
|
|
Hypertensive disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Furthermore, an M235T variant of the angiotensinogen (AGT) gene has been associated with hypertension, an important risk factor for the development and progression of diabetic nephropathy.
|
18413162 |
2008 |
|
rs1267969615
|
|
Myocardial Infarction
|
|
0.100 |
GeneticVariation
|
BEFREE |
Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction.
|
11531970 |
2001 |
|
rs1267969615
|
|
Diabetic Nephropathy
|
|
0.100 |
GeneticVariation
|
BEFREE |
A substitution (M235T) polymorphism in angiotensinogen (AGT) may interact with ACE I/D polymorphism for the risk of diabetic nephropathy, but their prognostic values have to be established by follow-up studies.
|
11181802 |
2001 |
|
rs1267969615
|
|
Hypertensive disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
In studies conducted in several different populations, the M235T substitution in the angiotensinogen (AGT) locus has been associated with hypertension.
|
9034402 |
1997 |
|
rs1267969615
|
|
Hypertensive disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
The ACE I/D polymorphism does not contribute to the presence and severity of essential hypertension, while the AGT M235T TT genotype confers a significantly decreased risk for the development of hypertension in the population studied here.
|
15642127 |
2005 |
|
rs1267969615
|
|
Essential Hypertension
|
|
0.100 |
GeneticVariation
|
BEFREE |
Although polymorphisms in renin-angiotensin-aldosterone (RAA) system genes for angiotensinogen (AGT M235T), angiotensin-converting enzyme (ACE I/D), angiotensin II type 1 receptor (AT1 A/C1166), and aldosterone synthase (CYP11B2-344T/C) have been major targets for genetic investigation in association with essential hypertension (EH), the influence of these genetic factors is still to be determined.
|
17190732 |
2007 |
|
rs1267969615
|
|
Hypertensive disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
M235T polymorphism of the angiotensinogen gene and insertion/deletion polymorphism of the angiotensin-1 converting enzyme gene in essential arterial hypertension in Caucasians.
|
17448297 |
2007 |
|
rs1267969615
|
|
Myocardial Infarction
|
|
0.100 |
GeneticVariation
|
BEFREE |
This case-control study was initiated to investigate whether the ACEI/D and AGT M235T polymorphisms are associated with an increased risk for coronary heart disease (CHD) and MI.
|
9034401 |
1997 |